AAAAAA
Results:
1-8
|
Results: 8
Authors:
Stoller, KB
Bigelow, GE
Walsh, SL
Strain, EC
Citation: Kb. Stoller et al., Effects of buprenorphine/naloxone in opioid-dependent humans, PSYCHOPHAR, 154(3), 2001, pp. 230-242
Authors:
Carter, JA
Herbst, JH
Stoller, KB
King, V
Kidorf, MS
Costa, PT
Brooner, RK
Citation: Ja. Carter et al., Short-term stability of NEO-PI-R personality trait scores in opioid-dependent outpatients, PSYCH ADDIC, 15(3), 2001, pp. 255-260
Authors:
King, VL
Kidorf, MS
Stoller, KB
Carter, JA
Brooner, RK
Citation: Vl. King et al., Influence of antisocial personality subtypes on drug abuse treatment response, J NERV MENT, 189(9), 2001, pp. 593-601
Authors:
King, VL
Kidorf, MS
Stoller, KB
Brooner, RK
Citation: Vl. King et al., Influence of psychiatric comorbidity on HIV risk behaviors: Changes duringdrug abuse treatment, J ADDICT D, 19(4), 2000, pp. 65-83
Authors:
Mintzer, RZ
Stoller, KB
Griffiths, RR
Citation: Rz. Mintzer et al., A controlled study of flumazenil-precipitated withdrawal in chronic low-dose benzodiazepine users, PSYCHOPHAR, 147(2), 1999, pp. 200-209
Authors:
King, VL
Brooner, RK
Kidorf, MS
Stoller, KB
Mirsky, AF
Citation: Vl. King et al., Attention deficit hyperactivity disorder and treatment outcome in opioid abusers entering treatment, J NERV MENT, 187(8), 1999, pp. 487-495
Authors:
Strain, EC
Stoller, KB
Citation: Ec. Strain et Kb. Stoller, Introduction and historical overview, METHADONE TREATMENT FOR OPIOID DEPENDENCE, 1999, pp. 1-14
Authors:
Stoller, KB
Bigelow, GE
Citation: Kb. Stoller et Ge. Bigelow, Regulatory, cost, and policy issues, METHADONE TREATMENT FOR OPIOID DEPENDENCE, 1999, pp. 15-37
Risultati:
1-8
|